Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma. The gene discussed is TFE3; the disease is hereditary clear cell renal cell carcinoma.